A detailed history of Walleye Trading LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Walleye Trading LLC holds 56,548 shares of VRNA stock, worth $6.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
56,548
Previous 38,500 46.88%
Holding current value
$6.05 Million
Previous $3.64 Million 65.67%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$90.08 - $106.69 $5.09 Million - $6.03 Million
56,548 New
56,548 $6.03 Million
Q1 2025

May 14, 2025

BUY
$44.81 - $69.63 $15,280 - $23,743
341 New
341 $21,000
Q4 2023

Feb 14, 2024

SELL
$11.94 - $20.47 $776 - $1,330
-65 Reduced 0.36%
18,065 $359,000
Q3 2023

Nov 21, 2023

BUY
$16.3 - $22.09 $295,519 - $400,491
18,130 New
18,130 $295,000

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $6.52B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.